API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 134 articles Forum Github 13 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. AVDL.NASDAQ

Avadel Pharmaceuticals PLC (AVDL NASDAQ) stock market data APIs

$14.72 0.23(1.6%) as of September 6, 2024
Price chart is built with Anychart

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Avadel Pharmaceuticals PLC Financial Data Overview

14.49
14.72
-
14.93
14.38
9.5-19.09
1 395 M
96 270 K
95 149 K
-0.14
1.632
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AVDL',
Type: 'Common Stock',
Name: 'Avadel Pharmaceuticals PLC',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00FPFX9W4',
ISIN: NULL,
CUSIP: NULL,
CIK: '1012477',
EmployerIdNumber: '98-1341933',
FiscalYearEnd: 'December',
IPODate: '1996-06-07',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: 'ADR',
IsDelisted: false,
}

Avadel Pharmaceuticals PLC Fundamental Data is available in our Financial Data APIs

  • Net Revenue 95 149 K
  • EBITDA -97 231 000
  • Earnings Per Share -1.09
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Avadel Pharmaceuticals PLC Earnings via APIs

  • Latest Release 2024-08-08
  • EPS/Forecast -0.16

Get Avadel Pharmaceuticals PLC End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Avadel Pharmaceuticals PLC latest news via APIs

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ™ Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

Avadel Pharmaceuticals plc – Survey data demonstrate 94% of people with narcolepsy prefer the once-nightly regimen of LUMRYZ over twice-nightly oxybate regimens – – 91% reported being better a...

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug

Avadel Pharma Shares Fall After Split Decision in Legal Fight Over Narcolepsy Drug
Do you have any questions?
support@eodhistoricaldata.com